Updated Jul 16, 2026
DeSimone Jill has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.61M.
Desimone Jill is listed in the 2026-06-12 SEC filing as a Director of Praxis Precision Medicines, Inc. This indicates she serves on Praxis Precision Medicines' board of directors. The provided SEC context does not include additional biographical details.
| Role | Director |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 837 | $315.70 | $264K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 1.3K | $314.90 | $403K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 504 | $313.66 | $158K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 1.0K | $312.83 | $314K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 2.9K | $311.91 | $890K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 1.8K | $310.89 | $544K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 999 | $309.38 | $309K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 1.2K | $308.24 | $382K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 683 | $306.77 | $210K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 320 | $305.31 | $98K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 120 | $303.13 | $36K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | S — Open-market sale | 10 | $301.44 | $3K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | M — Option exercise | 3.0K | $147.30 | $447K |
| 2026-06-26 | PRAX | Praxis Precision Medicines, Inc. | M — Option exercise | 8.6K | $44.25 | $379K |
| 2026-06-12 | PRAX | Praxis Precision Medicines, Inc. | A — Grant or award | 1.4K | $0.00 |
Desimone Jill is listed in the 2026-06-12 SEC filing as a Director of Praxis Precision Medicines, Inc. This indicates she serves on Praxis Precision Medicines' board of directors. The provided SEC context does not include additional biographical details.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($3.61M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DeSimone Jill profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.